🟢 Indaptus Therapeutics is trading 7.17% up today as biotechnology shares rebound

Indaptus Therapeutics is trading 7.17% up at $3.45 as biotechnology shares rebound and broader risk sentiment improves on September 17, 2026.

• The sector is supported by stronger pharmaceutical and biotech demand, improving funding conditions, and renewed M&A optimism.
• No new company-specific announcement was identified on September 17.
• The previously announced September 8 private placement, expected to raise approximately $24.0 million, remains relevant background but does not clearly explain today’s move.